Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity
NCT ID: NCT05578456
Last Updated: 2022-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
540 participants
INTERVENTIONAL
2022-11-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women
NCT03365466
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
NCT05698550
Effects of Vitamin D Status on the Outcome of Ivf - Embryo Transfer
NCT03503006
The Application of Zishen Yutai Pill in Aged Women Undergoing IVF-ET
NCT03703700
Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders
NCT03937661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
prednisone and aspirin
Prednisone and Aspirin
prednisone 10 mg and aspirin 75-100mg per day per os
placebo
Placebo
placebo 2 starch tablets per day per os
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prednisone and Aspirin
prednisone 10 mg and aspirin 75-100mg per day per os
Placebo
placebo 2 starch tablets per day per os
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ≥5 follicles with average diameter lager than 14 mm at trigger day
3. ≥5 oocytes retrieved
4. for frozen embryo transfer, at least 2 cleavage stage embryos, among which at least one morphologically good quality embryo, or at least 1 morphologically good quality embryo in blastocyst stage
5. age: 20-38 years old
6. Patients whose written ICF approved by the EC has been obtained, after having been duly informed of the nature of the study and voluntarily accepted to participate after being fully aware of the potential risks, benefits and any discomfort involved.
meet item 1, 5, 6, and one of item 2, 3, 4.
Exclusion Criteria
* intrauterine adhesion
* with endometrium thickness less than 6mm
* uterine malformation
* PGT
* with other autoimmune diseases need glucocorticoid or aspirin treatment
* gluacoma
* gastric ulcer
20 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ningbo Women & Children's Hospital
OTHER
Jinhua People's Hospital
OTHER
Jiaxing Maternity and Child Health Care Hospital
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Min Jin, Doctor
Role: PRINCIPAL_INVESTIGATOR
Zhejiang University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0513
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.